pharma news today glp-1 obesity drugs Agonists Weight Loss Market Report, 2025-2030 GLP-1 Drug Market: the rapid

Muscle cramps during GLP-1 therapy are typically caused by indirect factors including electrolyte depletion (especially magnesium and potassium) from gastrointestinal side effects, dehydration from reduced fluid intake or vomiting/diarrhea, rapid weight loss with some lean mass reduction, and increased physical activity exceeding current conditioning levels

Consult your healthcare provider about adding an osmotic laxative like polyethylene glycol (MiraLAX) temporarily while your body adjusts to the medication

Liraglutide in combination with acitretin for severe recalcitrant psoriasis

non-DM, b Matching variable for GLP-1 RA vs

Nausea is the most common GI side effect

What dosing protocols does the prescribing clinician follow